Jump to content

Recently poz


Guest pozbottom79

Recommended Posts

Guest pozbottom79

I tested poz 12 days back and the medical center started me on Biktarvy. They took blood on the day they started my meds for finding my viral load and it shows less than 40 copies per ml. T cell count is 1147. I have an appointment next week with the provider, but isn't that a low viral count for me being newly diagnosed? I thought under 40 is undetectable?

 

Genuinely asking. 

Link to comment
Share on other sites

Guest Descartes70817

Nowadays anything under 20 is undetectable but if you've just started on meds it takes a while to clear out the dead viruses still in your system, and the debris will still show up in your labs. My ID doctor told me that realistically anything under 200 is un-infectious though.

Edited by Descartes70817
Link to comment
Share on other sites

Guest pozbottom79

The thing is the day they took the blood (9 days ago), I hadnt even started on meds (I started meds the next day). So I am a little surprised that my viral load is showing as under 40. They had expected much higher values. Was wondering if this might have happened to someone else

Link to comment
Share on other sites

1 hour ago, pozbottom79 said:

I tested poz 12 days back and the medical center started me on Biktarvy. They took blood on the day they started my meds for finding my viral load and it shows less than 40 copies per ml. T cell count is 1147. I have an appointment next week with the provider, but isn't that a low viral count for me being newly diagnosed? I thought under 40 is undetectable?

 

Genuinely asking. 

Sometimes, if you've been infected awhile your body will naturally fight and you may get results like those. SOme people are also "non Progressors" whose CD4 never falls.  Good Luck

Link to comment
Share on other sites

As others have noted, the human body can do a fairly good job (at first) at keeping the virus at bay after an initial infection surge in the viral load. Depending on when you were infected, you could be in that stage.

That's a good thing for your long-term health prognosis. It means your body has good "reserves" of healthy t-cells, so if your treatment keeps the virus itself knocked down, your body can deal with all the other things that come up along the way just like anyone else. 

Biktarvy is also a medication that is "friendly" to other parts of your body, like your kidneys. That means by itself, it shouldn't push you into having dysfunctional kidneys or kidney disease. 

  • Like 1
Link to comment
Share on other sites

Guest pozbottom79
21 hours ago, BootmanLA said:

As others have noted, the human body can do a fairly good job (at first) at keeping the virus at bay after an initial infection surge in the viral load. Depending on when you were infected, you could be in that stage.

That's a good thing for your long-term health prognosis. It means your body has good "reserves" of healthy t-cells, so if your treatment keeps the virus itself knocked down, your body can deal with all the other things that come up along the way just like anyone else. 

Biktarvy is also a medication that is "friendly" to other parts of your body, like your kidneys. That means by itself, it shouldn't push you into having dysfunctional kidneys or kidney disease. 

The medical center has informed me that while I have the virus, I am either an extremely slow progressor or a non progressor, which makes me a rare minority, and a lucky one. That means my body has been able to keep the virus at bay almost entirely (they cannot find an exact number of viral copies under 40 in the test that they use, and cannot genome sequence either). So meds continue, but long term this is the best from a survival POV

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use, Privacy Policy, and Guidelines. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.